BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35781165)

  • 21. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
    Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
    Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-collected versus medic-collected sampling for human papillomavirus testing among women in Lagos, Nigeria: a comparative study.
    Feng N; Ezechi O; Uwandu M; Abimbola BS; Vincent GD; Idigbe I; Okoli LC; Adesina M; Okwuzu J; Ahmed RA; Sokei J; Shaibu JO; Momoh AE; Sowunmi O; Labo-Popoola OH; ; Ohihoin G; David A; Nzeribe E; Olaleye O; Dong XP; Onwuamah CK
    BMC Public Health; 2022 Oct; 22(1):1922. PubMed ID: 36243709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of high-risk human papillomavirus infections using clinician- and self-collected cervical sampling methods in rural women from far western Nepal.
    Johnson DC; Bhatta MP; Smith JS; Kempf MC; Broker TR; Vermund SH; Chamot E; Aryal S; Lhaki P; Shrestha S
    PLoS One; 2014; 9(6):e101255. PubMed ID: 24978811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women.
    Bergengren L; Kaliff M; Larsson GL; Karlsson MG; Helenius G
    Int J Gynaecol Obstet; 2018 Sep; 142(3):359-364. PubMed ID: 29856071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis of agreement/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening.
    Arbyn M; Castle PE; Schiffman M; Wentzensen N; Heckman-Stoddard B; Sahasrabuddhe VV
    Int J Cancer; 2022 Jul; 151(2):308-312. PubMed ID: 35179777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region.
    Hesselink AT; Berkhof J; van der Salm ML; van Splunter AP; Geelen TH; van Kemenade FJ; Bleeker MG; Heideman DA
    J Clin Microbiol; 2014 Mar; 52(3):890-6. PubMed ID: 24391196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
    Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
    Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
    Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
    BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial.
    Gizaw M; Teka B; Ruddies F; Abebe T; Kaufmann AM; Worku A; Wienke A; Jemal A; Addissie A; Kantelhardt EJ
    Cancer Prev Res (Phila); 2019 Sep; 12(9):609-616. PubMed ID: 31337647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utilizing first void urine for high-risk HPV testing for cervical cancer screening in HIV-positive women in Katete, Zambia.
    Kaoma M; Olayemi O; Mwaba MH; Sikwewa K
    BMC Womens Health; 2023 Feb; 23(1):62. PubMed ID: 36774526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
    Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
    Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens.
    Toliman P; Badman SG; Gabuzzi J; Silim S; Forereme L; Kumbia A; Kombuk B; Kombati Z; Allan J; Munnull G; Ryan C; Vallely LM; Kelly-Hanku A; Wand H; Mola GDL; Guy R; Siba P; Kaldor JM; Tabrizi SN; Vallely AJ
    J Clin Microbiol; 2016 Jul; 54(7):1734-1737. PubMed ID: 27076663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-obtained vaginal samples for HPV DNA testing to detect HPV-related cervical disease.
    Kim MH; Jung HJ; Park SI; Kim BJ
    Int J Gynaecol Obstet; 2021 Jul; 154(1):127-132. PubMed ID: 33368281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis.
    Nelson EJ; Maynard BR; Loux T; Fatla J; Gordon R; Arnold LD
    Sex Transm Infect; 2017 Feb; 93(1):56-61. PubMed ID: 28100761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance and pre-analytical stability of self-collected samples versus clinician cervical samples for the detection of HPV16, HPV18 and a pool of 12 other HPV types on the Roche Cobas 8800 System.
    Ilardo C; Marguerettaz M; Breton A; Azzoug T; Schmitt N; Fournier R; Bayette J; Teissier G; Lelarge C; Ponseille B
    New Microbiol; 2022 Apr; 45(2):111-114. PubMed ID: 35699559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-sampling for human papillomavirus DNA detection: a preliminary study of compliance and feasibility in BOLIVIA.
    Surriabre P; Allende G; Prado M; Cáceres L; Bellot D; Torrico A; Ustariz K; Rojas S; Barriga J; Calle P; Villarroel L; Yañez RM; Baay M; Rodriguez P; Fontaine V
    BMC Womens Health; 2017 Dec; 17(1):135. PubMed ID: 29273032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling.
    Shin HY; Lee B; Hwang SH; Lee DO; Sung NY; Park JY; Jun JK
    J Gynecol Oncol; 2019 Sep; 30(5):e76. PubMed ID: 31328458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 40. Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials.
    Di Gennaro G; Licata F; Trovato A; Bianco A
    Front Public Health; 2022; 10():1003461. PubMed ID: 36568753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.